Noida-based startup Redcliffe Labs, a purpose-driven PAN India diagnostic service provider, has announced the launch of its advanced MPOX testing capabilities, reinforcing its commitment to national health security. 

This strategic move is a significant step towards bolstering the nation’s preparedness against potential MPOX outbreaks.

With its widespread network of 80+ in-house world-class labs, 2000+ collection centres, and presence in 220+ cities, Redcliffe Labs played a crucial role in combating the COVID-19 pandemic across both waves and is once again at the forefront of safeguarding public health.

MPOX, a highly contagious viral disease increasingly recognised for its potential to cause localised outbreaks, poses significant public health risks if not detected and controlled promptly. With several cases reported in Africa, Europe, and parts of Asia, the urgency of this threat necessitates early preparedness and timely intervention to prevent the virus from spreading. 

Redcliffe Labs has proactively assured key health authorities, including Noida's Chief Medical Officer (CMO) and the Indian Council of Medical Research (ICMR), of its readiness to manage the MPOX situation. Being prepared with advanced testing facilities not only ensures the rapid identification and isolation of cases but also guarantees that healthcare providers are fully equipped to handle increased demand. Additionally, it enables timely public communication and education, reducing misinformation and helping manage the community impact.